Katarzyna Pogoda

12PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersClinical midwiferyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 26, 2026
Clinical Decision-Making After Receptor Conversion Following Neoadjuvant Therapy in Breast Cancer: A Three-Strategy Framework.

|Jun 30, 2026
Dynamics of HER2 status following neoadjuvant systemic therapy in breast cancer: a large single-center cohort analysis.

|Apr 27, 2026
Post-Chemotherapy Antibody-Based Continuation and Maintenance Strategies in HER2-Positive Metastatic Breast Cancer: A Translational Narrative Review.

|Jan 21, 2026
Antibody-Based Therapeutics in Breast Cancer: Clinical and Translational Perspectives.

Anna Balata, Katarzyna Pogoda

|Dec 30, 2025
Management Strategies and Outcomes in HR+/HER2- Metastatic Breast Cancer Receiving CDK4/6 Inhibitors and Subsequent Therapies.

Katarzyna Pogoda, Hubert Pawlik, Anna Balata

|Mar 28, 2025
Neurofilaments as Prognostic Biomarkers in the Assessment of the Risk of Advanced Taxane-Induced Neuropathy in Breast Cancer Patients-A Pilot Study.

Agata Makówka, Malgorzata Fuksiewicz, Anna Bałata

Pageof 2

Frequent Collaborators

3 joint publications

Agnieszka Jagiełło-Gruszfeld

2 joint publications

Anna Balata

2 joint publications

Laura De Marchis

2 joint publications

Piotr Jan Wysocki